Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders

Gastroesophageal Reflux Disease (GERD)

Mucosal Impedance: a New Approach to Diagnosing Gastroesophageal Reflux Disease and Eosinophilic Esophagitis

Curr Gastroenterol Rep.

Barrett C, Choksi Y, Vaezi MF

doi: 10.1007/s11894-018-0639-4.

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

Ann Gastroenterol.

de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S

doi: 10.20524/aog.2018.0314.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease

J Formos Med Assoc.

Lei WY, Chang WC, Wen SH, Wong MW, Hung JS, Yi CH, Liu TT, Hsu CS, Orr WC, Vaezi MF, Pace F, Hsieh TC, Chen CL

doi: 10.1016/j.jfma.2018.12.00

Gastroesophageal Reflux Disease (GERD)

The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease

Am J Gastroenterol.

Yadlapati R, Pandolfino JE, Alexeeva O, Gregory DL, Craven MR, Liebovitz D, Lichten A, Seger E, Workman M, St Peter N, Craft J, Doerfler B, Keswani RN

doi: 10.1038/ajg.2017.262.

Gastroesophageal Reflux Disease (GERD)

Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility

J Gastrointest Surg.

Armijo PR, Hennings D, Leon M, Pratap A, Wheeler A, Oleynikov D

doi: 10.1007/s11605-018-3968-6.

Inflammatory Bowel Disease

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Inflamm Bowel Dis.

Attauabi M, Zhao M, Bendtsen F, Burisch J

doi: 10.1093/ibd/izaa167.

Gastroesophageal Reflux Disease (GERD)

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries

JAMA Oncol.

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J

doi: 10.1001/jamaoncol.2018.3054.

Esophagus DiseasesGastroesophageal Reflux Disease (GERD)

Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis

Surg Endosc.

Yan J, Strong AT, Sharma G, Gabbard S, Thota P, Rodriguez J, Kroh M

doi: 10.1007/

Gastrointestinal CancerGastroesophageal Reflux Disease (GERD)

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease

doi: 10.1007/

Related content

Mucosal Impedance: a New Approach to Diagnosing Gastroesophageal Reflux Disease and Eosinophilic Esophagitis

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease

The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease

Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries

Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease